id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-322322-woz6lwdu	Marcum, Michelle	COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective	2020-07-10		.txt	text/plain	3153	151	42	authors: Marcum, Michelle; Kurtzweil, Nicky; Vollmer, Christine; Schmid, Lisa; Vollmer, Ashley; Kastl, Alison; Acker, Kelly; Gulati, Shuchi; Grover, Punita; Herzog, Thomas J.; Ahmad, Syed A.; Sohal, Davendra; Wise‐Draper, Trisha M. Remote telephone and video visits, remote monitoring, electronic capture of signatures and data, and limiting sample collections have allowed the leadership in our institution to ensure the safety of our staff and patients while continuing critical clinical research operations. In addition, the decision whether to continue cancer clinical trials became a safety concern regarding the treatment effect on cancer patients' vulnerability for COVID-19 contraction, potential viral exposure risk to clinical trial staff, and potential impact of an infected clinical trial cancer patient on study outcomes. With the advent of COVID-19 travel restrictions, the University of Cincinnati Cancer Center (UCCC) Clinical Trials Office (CTO) was well positioned to continue with existing remote monitoring of sub-site EMRs, regulatory and pharmacy source documents, and we have utilized the ability of the REDCap database for electronic data capture to identify and resolve data quality items remotely.	./cache/cord-322322-woz6lwdu.txt	./txt/cord-322322-woz6lwdu.txt